Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3827 ARTÍCULOS , VIENDO DEL 2536 AL 2550

Antisense oligonucleotides: treating neurodegeneration at the level of RNA

DeVos SL, Miller TM.

Neurotherapeutics. 2013 Jul;10(3):486-97. doi: 10.1007/s13311-013-0194-5.

Transglutaminase inhibition as a possible therapeutical approach to protect cells from death in neurodegenerative diseases

Iannaccone M, Serretiello E, De Vivo G, Martin A, Stefanile A, Titta F, Gentile V.

Recent Pat CNS Drug Discov. 2013 Aug;8(2):161-8. doi: 10.2174/15748898113089990001.

Sirtuin deacetylases in neurodegenerative diseases of aging

Herskovits AZ, Guarente L.

Cell Res. 2013 Jun;23(6):746-58. doi: 10.1038/cr.2013.70. Epub 2013 May 21.

Autophagy in physiological and pathological processes--selected aspects

Niedźwiedzka-Rystwej P, Tokarz-Deptuła B, Deptuła W.

Pol J Vet Sci. 2013;16(1):173-80. doi: 10.2478/pjvs-2013-0026.

[A patient with asbestosis, chorea and neuropsychiatric symptoms]

Torreman M, de Lange DC.

Tijdschr Gerontol Geriatr. 2013 Jun;44(3):143-8. doi: 10.1007/s12439-013-0020-x.

3-(2-(S)-3,4-Dehydropyrrolinyl methoxy)-5-(3'-[(18)F]fluoropropyl)pyridine

Leung K.

2013 Mar 18 [updated 2013 May 23]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013.

Gene therapy for misfolding protein diseases of the central nervous system

San Sebastian W, Samaranch L, Kells AP, Forsayeth J, Bankiewicz KS.

Neurotherapeutics. 2013 Jul;10(3):498-510. doi: 10.1007/s13311-013-0191-8.

Cognitive reserve and brain reserve in prodromal Huntington's disease

Bonner-Jackson A, Long JD, Westervelt H, Tremont G, Aylward E, Paulsen JS; PREDICT-HD Investigators and Coordinators of the Huntington Study Group.

J Int Neuropsychol Soc. 2013 Aug;19(7):739-50. doi: 10.1017/S1355617713000507. Epub 2013 May 23.

Rheumatic fever & rheumatic heart disease: the last 50 years

Kumar RK, Tandon R.

Indian J Med Res. 2013 Apr;137(4):643-58.

Epigenetic targeting of histone deacetylase: therapeutic potential in Parkinson's disease?

Harrison IF, Dexter DT.

Pharmacol Ther. 2013 Oct;140(1):34-52. doi: 10.1016/j.pharmthera.2013.05.010. Epub 2013 May 24.

Clinical, laboratory and electrophysiological features of Morvan's fibrillary chorea

Lee W, Day TJ, Williams DR.

J Clin Neurosci. 2013 Sep;20(9):1246-9. doi: 10.1016/j.jocn.2012.10.029. Epub 2013 May 24.

Yeast as a platform to explore polyglutamine toxicity and aggregation

Duennwald ML.

Methods Mol Biol. 2013;1017:153-61. doi: 10.1007/978-1-62703-438-8_11.

Nucleotide excision repair in chronic neurodegenerative diseases

Sepe S, Payan-Gomez C, Milanese C, Hoeijmakers JH, Mastroberardino PG.

DNA Repair (Amst). 2013 Aug;12(8):568-77. doi: 10.1016/j.dnarep.2013.04.009. Epub 2013 May 28.

Transcranial magnetic stimulation as a tool for understanding neurophysiology in Huntington's disease: a review

Philpott AL, Fitzgerald PB, Cummins TD, Georgiou-Karistianis N.

Neurosci Biobehav Rev. 2013 Sep;37(8):1420-33. doi: 10.1016/j.neubiorev.2013.05.009. Epub 2013 May 29.

Association between caffeine intake and age at onset in Huntington's disease

Simonin C, Duru C, Salleron J, Hincker P, Charles P, Delval A, Youssov K, Burnouf S, Azulay JP, Verny C, Scherer C, Tranchant C, Goizet C, Debruxelles S, Defebvre L, Sablonnière B, Romon-Rousseaux M, Buée L, Destée A, Godefroy O, Dürr A, Landwehrmeyer B; REGISTRY Study of the European Huntington's Disease Network; Bachoud-Levi AC, Richard F, Blum D, Krystkowiak P; Huntington French Speaking Network.

Neurobiol Dis. 2013 Oct;58:179-82. doi: 10.1016/j.nbd.2013.05.013. Epub 2013 May 31.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias